おすすめ市販薬を最速で選ぶ bannerおすすめ市販薬を最速で選ぶ banner
おすすめ市販薬を最速で選ぶおすすめ市販薬を最速で選ぶ

おすすめ市販薬を最速で選ぶ

Japan@おすすめ市販薬を最速で選ぶ  •  Joined July 20, 2021

Live
Sub 31.7K  |  View 4.84M  |  Video 193
#854,555
#20,534Japan
#1,007,128
#26,025Japan

At a glance

Subscribers

Last 14 days

31.7K

+100 (+0.3%)

Views

Last 14 days

4.84M

+29.1K (+0.6%)

Videos

Last 14 days

193

+1 (+0.5%)

Charts

Subscribers, views & videos over time

Tap on chart to see values
Loading chart...

Subscribers gained (weekly) · 6 mo

Loading chart...

Views gained (weekly) · 6 mo

Loading chart...

Subs milestone changes (up to 30)

Loading chart...

Views milestone changes (up to 30)

Loading chart...

Engagement

Avg. views per video

25.1K

Total views ÷ total videos

Views per subscriber

152×

Total views ÷ subscribers

Subs per video

165

Subscribers ÷ total videos

Revenue estimate

Details →

Total (all-time): $3.39K – $9.69K

Daily avg.: $1 – $4

Weekly avg.: $10 – $29

Last 14 days: $20 – $58

Based on estimated $0.7–$2 CPM.

Analytics tables

Analytics Table:おすすめ市販薬を最速で選ぶ

Date
subscribers
views
videos
Jun 1, 2026
Jun 1
Mon
31.7K
--
4.84M
+14.4K
193
--
May 25, 2026
May 25
Mon
31.7K
+100
4.83M
+14.7K
193
+1
May 24, 2026
May 24
Sun
31.6K
+100
4.81M
+33.9K
192
--
May 7, 2026
May 7
Thu
31.5K
--
4.78M
--
192
--

Subscribers gained (weekly)

WeekSubscribers gainedChange vs prev
May 24, 2026
100
+100
May 25, 2026
100
--
Jun 1, 2026
0
-100

Views gained (weekly)

WeekViews gainedChange vs prev
May 24, 2026
33.9K
+33.9K
May 25, 2026
14.7K
-19.2K
Jun 1, 2026
14.4K
-293

About

日本で1番市販薬の情報を多く発信している薬剤師です。 市販薬を学ぶオンラインスクールを開校中です。 病院薬剤師ですが市販薬の勉強・情報発信を行っています。 市販薬の選び方が分からない人はもちろん、これから市販薬を学びたい医薬品登録販売者や薬剤師に向けても情報を発信しています。 【オンラインスクール】 https://college.coeteco.jp/bundles/N8rWs1vP 【ブログ】 http://allegra.tokyo/otc/ 【note】 https://note.com/tkcnr 【X】 https://twitter.com/tkcnr339

Joined
July 20, 2021

Growth Rankings

JapanJapan · Education

Subs gained

#860

Views gained

#1,138

Categories

EducationHow To And StylePeople And Blogs

More features coming

We're working on new analytics and tools. Stay tuned.